Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 676K | $100M | $148.50 | Dec 31, 2021 | By the Declan Doogan 2014 Trust |
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 633K | $94M | $148.50 | Nov 30, 2021 | Declan Doogan Revocable Trust |
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 180K | $26.8M | $148.50 | Oct 14, 2021 | Dorothy Doogan 2020 Trust |
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 7.34K | $1.09M | $148.50 | Oct 14, 2021 | Dorothy Doogan Revocable Trust |
TENAX THERAPEUTICS, INC. | Director, 10%+ Owner | Common Stock | 3.64M | Aug 11, 2022 | Direct | ||
TENAX THERAPEUTICS, INC. | Director, 10%+ Owner | Stock Option (right to buy) | 6.25K | Aug 11, 2022 | Direct | ||
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 0 | $148.50 | Oct 14, 2021 | Declan Doogan 2021 Trust | |
Biohaven Pharmaceutical Holding Co Ltd. | Director | Common Shares | 0 | $148.50 | Nov 30, 2021 | Direct | |
TENAX THERAPEUTICS, INC. | Director, 10%+ Owner | Common Stock | 0 | Aug 11, 2022 | By Declan Doogan 2021 GRAT DTD 03-04-2021 |